Karachi: Ferozsons Laboratories Limited has announced that its Board of Directors will convene on April 29, 2025, via video link to review the company's quarterly accounts for the period ending March 31, 2025. The meeting will also consider the declaration of any entitlements.

In compliance with the Pakistan Stock Exchange (PSX) regulations, Ferozsons Laboratories has declared a closed period from April 22, 2025, to April 29, 2025. During this time, no director, CEO, or executive of the company is permitted to engage in any direct or indirect transactions involving the company's shares.

According to information available from the Pakistan Stock Exchange (PSX), this measure is in line with regulatory requirements to ensure transparency and prevent insider trading during sensitive financial disclosures.

Market participants and TRE Certificate Holders have been requested to take note of the closed period and the upcoming meeting, as it may influence trading activities and share valuations in the healthcare and pharmaceuticals designated market category.